Beverly Hills, CA (PRWEB) January 15, 2013
OXIS International, Inc., (OTCBB:OXIS) (Paris:OXI) today announced it has surpassed the 4,000 order milestone and continues to successfully market its skin care line in the competitive beauty landscape. Order rates following trials are well above 70% which, amongst other quality attributes, speaks to the positive anti-aging effects of EGT™ the world’s only intelligent anti-oxidant. EGT™ is referred to as the "intelligent antioxidant" as it is the only anti-oxidant having a dedicated transport mechanism in the body to deliver it through the cell membrane and into the mitochondria, the energy producing area of the cell.
Joint venture partner Engage:BDR is continuing to optimize the successful campaign. “Due to very positive performance in the US and Canada during the latter half of 2012, we are preparing to launch the products Prograce (http://www.prograceyou.com) and Reverge (http://www.revergeyou.com) into the United Kingdom and Australia next month,” stated Engage:BDR CEO Ted Dhanik.
David Saloff, OXIS Chairman and CEO stated, "I couldn’t be more pleased with our initial market test in North America. Sales continue and are scheduled to scale significantly in February in North America, Europe, and Australia.”
About OXIS International, Inc.
OXIS International, Inc. develops technologies and products to research, diagnose, treat and prevent diseases of oxidative stress/inflammation associated with damage from free radical and Reactive Oxygen Species (ROS). The company holds the exclusive patent to manufacture EGT, which has received full GRAS (safety) approval. In addition the company holds the rights to several therapeutic classes of compounds in the area of oxidative stress, including EGT(TM) (99% pure L-ergothioneine), known as the intelligent antioxidant.